Pure Global AI
NCT06309186Recruiting

Empowerment and Burnout of Midwives at the End of Health Emergency From COVID-19

Empowerment and Burnout of Midwives at the End of Health Emergency From SARS-CoV2: a Cross-sectional Observational Study in Friuli-Venezia Giulia Region
IRCCS Burlo GarofoloClinicalTrials.govother
Study focus
Disease/Condition
COVID-19
Drug/Device/Intervention
Evaluation of midwifes' burnout
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
IRCCS Burlo Garofolo
Location
Trieste, Italy
Timeline & enrollment
Phase
N/A
Start date
Jan 09, 2023
End date
Dec 31, 2024
Enrollment
64 participants
Primary outcome

Evaluation of empowerment of midwives,Number of midwives affected by burnout

Summary

As the fifth wave of COVID-19 comes to an end and the pandemic's countermeasures expire,
 there is a need to assess the impact of the pandemic on health care providers, especially
 midwives, as the professionals deputed to promote and protect women's holistic health, in all
 phases, physiological and otherwise, of the life cycle. The midwife considers the person as a
 whole, in which the mind-body-culture components interact profoundly. Prevention and
 containment measures have impacted on midwifery clinical and nursing practices with the
 mandatory continuous use of personal protective equipments (PPE) and social distancing to
 protect the patient and the practitioner, effectively hindering the intimacy of the
 woman-midwife relationship. The impact assessment focuses on two dimensions: learning,
 investigated as perceived empowerment, and perceived malaise, investigated as burnout.
 Empowerment has a positive connotation, which can offset burnout, a syndrome that affects the
 physical, psychological and emotional health of midwives and can have significant negative
 implications on midwife turnover, patient safety and outcomes, and the efficiency of
 healthcare organisations.

ICD-10 classifications
COVID-19, virus identifiedCOVID-19, virus not identifiedCoronavirus infection, unspecified siteViral infection, unspecifiedRift Valley fever
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06309186
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06309186 through Pure Global AI's free database. This phase not specified trial is sponsored by IRCCS Burlo Garofolo and is currently Recruiting. The study focuses on COVID-19. Target enrollment is 64 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.